XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
6.62
+0.13 (2.00%)
Nov 21, 2024, 4:00 PM EST - Market closed
XBiotech Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 202 | 122 | 107 | 338 | 458 | 767 | |
| Market Cap Growth | 87.79% | 13.95% | -68.42% | -26.11% | -40.29% | 321.45% | |
| Enterprise Value | 29 | -80 | -113 | 99 | 219 | 727 | |
| Last Close Price | 6.62 | 4.00 | 3.51 | 11.13 | 13.51 | 16.11 | |
| PE Ratio | - | - | - | - | - | 1.12 | |
| Forward PE | - | 87.63 | 87.63 | 87.63 | 87.63 | - | |
| PS Ratio | - | - | 26.64 | 18.39 | 10.41 | - | |
| PB Ratio | 1.05 | 0.56 | 0.44 | 1.26 | 1.31 | 1.01 | |
| P/TBV Ratio | 1.23 | 0.56 | 0.44 | 1.26 | 1.31 | 1.01 | |
| P/FCF Ratio | - | - | - | 5.13 | - | - | |
| P/OCF Ratio | - | - | - | 4.87 | - | - | |
| EV/Sales Ratio | - | - | - | 5.41 | 4.99 | - | |
| EV/FCF Ratio | - | - | - | 1.51 | - | - | |
| Asset Turnover | - | - | 0.02 | 0.06 | 0.08 | - | |
| Quick Ratio | 11.51 | 32.94 | 53.92 | 71.22 | 62.26 | 11.87 | |
| Current Ratio | 11.57 | 33.07 | 54.07 | 71.49 | 81.80 | 11.90 | |
| Return on Equity (ROE) | -15.75% | -10.69% | -12.91% | -5.64% | -2.03% | 167.78% | |
| Return on Assets (ROA) | -12.03% | -9.92% | -8.27% | -4.99% | -1.95% | -4.53% | |
| Return on Capital (ROIC) | -12.45% | -10.21% | -8.46% | -5.07% | -2.07% | -4.90% | |
| Earnings Yield | -16.18% | -20.17% | -30.79% | -5.15% | -2.45% | 87.19% | |
| FCF Yield | -14.47% | -15.68% | -14.42% | 19.48% | -15.04% | -2.41% | |
| Buyback Yield / Dilution | -0.06% | 0.00% | -1.32% | 2.53% | 33.45% | -29.37% | |
| Total Shareholder Return | -0.06% | 0.00% | -1.32% | 2.53% | 33.45% | -29.37% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.